Nuveen Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $12.9M | Buy |
319,868
+1,868
| +0.6% | +$75.2K | ﹤0.01% | 1461 |
|
|
2024
Q3 | $20.1M | Buy |
318,000
+115,307
| +57% | +$7.3M | 0.01% | 1193 |
|
|
2024
Q2 | $10.7M | Sell |
202,693
-258,389
| -56% | -$13.7M | ﹤0.01% | 1534 |
|
|
2024
Q1 | $37.8M | Buy |
461,082
+193,462
| +72% | +$15.9M | 0.01% | 772 |
|
|
2023
Q4 | $4.98M | Buy |
267,620
+3,336
| +1% | +$62.1K | ﹤0.01% | 1980 |
|
|
2023
Q3 | $2.93M | Sell |
264,284
-311
| -0.1% | -$3.44K | ﹤0.01% | 2134 |
|
|
2023
Q2 | $4.29M | Buy |
264,595
+251,647
| +1,944% | +$4.08M | ﹤0.01% | 1993 |
|
|
2023
Q1 | $216K | Buy |
+12,948
| New | +$216K | ﹤0.01% | 2979 |
|
|
2022
Q2 | – | Sell |
-263,132
| Closed | -$855K | – | 3405 |
|
|
2022
Q1 | $855K | Sell |
263,132
-522,881
| -67% | -$1.7M | ﹤0.01% | 2866 |
|
|
2021
Q4 | $3.57M | Sell |
786,013
-327,359
| -29% | -$1.49M | ﹤0.01% | 2289 |
|
|
2021
Q3 | $7.45M | Buy |
1,113,372
+829,824
| +293% | +$5.55M | ﹤0.01% | 1987 |
|
|
2021
Q2 | $1.7M | Sell |
283,548
-13,210
| -4% | -$79.1K | ﹤0.01% | 2786 |
|
|
2021
Q1 | $1.88M | Sell |
296,758
-13,262
| -4% | -$83.9K | ﹤0.01% | 2652 |
|
|
2020
Q4 | $1.75M | Sell |
310,020
-191,168
| -38% | -$1.08M | ﹤0.01% | 2576 |
|
|
2020
Q3 | $2.92M | Buy |
501,188
+252,718
| +102% | +$1.47M | ﹤0.01% | 2199 |
|
|
2020
Q2 | $1.79M | Sell |
248,470
-5,956
| -2% | -$42.9K | ﹤0.01% | 2387 |
|
|
2020
Q1 | $1.19M | Sell |
254,426
-533
| -0.2% | -$2.5K | ﹤0.01% | 2428 |
|
|
2019
Q4 | $2.05M | Sell |
254,959
-167,442
| -40% | -$1.34M | ﹤0.01% | 2412 |
|
|
2019
Q3 | $2.91M | Buy |
422,401
+143,876
| +52% | +$990K | ﹤0.01% | 2236 |
|
|
2019
Q2 | $2.31M | Buy |
+278,525
| New | +$2.31M | ﹤0.01% | 2368 |
|
|
2019
Q1 | – | Sell |
-82,960
| Closed | -$635K | – | 1070 |
|
|
2018
Q4 | $635K | Buy |
82,960
+54,731
| +194% | +$419K | ﹤0.01% | 782 |
|
|
2018
Q3 | $492K | Buy |
+28,229
| New | +$492K | ﹤0.01% | 865 |
|